Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

A Chow

Showing results (401-410 of 440) with videos related to

Pageof 44
Sort By:
American Journal of Hematology|January 22, 2019
Eligibility for CAR T-cell therapy: An analysis of selection criteria and survival outcomes in chemorefractory DLBCLStephen D Smith, Prathima Reddy, Alexandra Sokolova, et al.
Blood Advances|October 14, 2021
Megadose 90Y-ibritumomab tiuxetan prior to allogeneic transplantation is effective for aggressive large B-cell lymphomaVictor A Chow, Ryan D Cassaday, Theodore A Gooley, et al.
Cancer Chemotherapy and Pharmacology|March 27, 2009
Phase I trial of GTI-2040, oxaliplatin, and capecitabine in the treatment of advanced metastatic solid tumors: a California Cancer Consortium StudyStephen I Shibata, James H Doroshow, Paul Frankel, et al.
Cancer|September 16, 2006
Asian American Network for Cancer Awareness, Research, and Training's legacy. The first 5 yearsMoon S Chen, Susan M Shinagawa, Dileep G Bal, et al.
American Journal of Hematology|April 4, 2020
A phase II trial evaluating the efficacy of high-dose Radioiodinated Tositumomab (Anti-CD20) antibody, etoposide and cyclophosphamide followed by autologous transplantation, for high-risk relapsed or refractory non-hodgkin lymphomaVictor A Chow, Joseph G Rajendran, Darrell R Fisher, et al.
Cancer Chemotherapy and Pharmacology|June 3, 2004
Feasibility and pharmacokinetic study of infusional dexrazoxane and dose-intensive doxorubicin administered concurrently over 96 h for the treatment of advanced malignanciesWarren A Chow, Timothy W Synold, Merry L Tetef, et al.
Epidemiology and Psychiatric Sciences|April 9, 2016
Two-year follow-up of a Chinese sample at clinical high risk for psychosis: timeline of symptoms, help-seeking and conversionT H Zhang, H J Li, K A Woodberry, et al.
Leukemia & Lymphoma|July 11, 2022
Predictors of cytopenias after treatment with axicabtagene ciloleucel in patients with large B-cell lymphomaLorena Panaite, Qian Vicky Wu, Jenna Voutsinas, et al.
Hong Kong Medical Journal = Xianggang Yi Xue Za Zhi|February 8, 2012
Effect of influenza on cardiorespiratory and all-cause mortality in Hong Kong, Singapore and GuangzhouC M Wong, J S M Peiris, L Yang, et al.
Plos One|April 6, 2017
Development of an enzyme immunoassay for detection of antibodies against Coccidioides in dogs and other mammalian speciesNancy A Chow, Mark D Lindsley, Orion Z McCotter, et al.
Pageof 44

Showing results (401-410 of 440) with videos related to

Sort By:
Pageof 44
American Journal of Hematology|January 22, 2019
Eligibility for CAR T-cell therapy: An analysis of selection criteria and survival outcomes in chemorefractory DLBCLStephen D Smith, Prathima Reddy, Alexandra Sokolova, et al.
Blood Advances|October 14, 2021
Megadose 90Y-ibritumomab tiuxetan prior to allogeneic transplantation is effective for aggressive large B-cell lymphomaVictor A Chow, Ryan D Cassaday, Theodore A Gooley, et al.
Cancer Chemotherapy and Pharmacology|March 27, 2009
Phase I trial of GTI-2040, oxaliplatin, and capecitabine in the treatment of advanced metastatic solid tumors: a California Cancer Consortium StudyStephen I Shibata, James H Doroshow, Paul Frankel, et al.
Cancer|September 16, 2006
Asian American Network for Cancer Awareness, Research, and Training's legacy. The first 5 yearsMoon S Chen, Susan M Shinagawa, Dileep G Bal, et al.
American Journal of Hematology|April 4, 2020
A phase II trial evaluating the efficacy of high-dose Radioiodinated Tositumomab (Anti-CD20) antibody, etoposide and cyclophosphamide followed by autologous transplantation, for high-risk relapsed or refractory non-hodgkin lymphomaVictor A Chow, Joseph G Rajendran, Darrell R Fisher, et al.
Cancer Chemotherapy and Pharmacology|June 3, 2004
Feasibility and pharmacokinetic study of infusional dexrazoxane and dose-intensive doxorubicin administered concurrently over 96 h for the treatment of advanced malignanciesWarren A Chow, Timothy W Synold, Merry L Tetef, et al.
Epidemiology and Psychiatric Sciences|April 9, 2016
Two-year follow-up of a Chinese sample at clinical high risk for psychosis: timeline of symptoms, help-seeking and conversionT H Zhang, H J Li, K A Woodberry, et al.
Leukemia & Lymphoma|July 11, 2022
Predictors of cytopenias after treatment with axicabtagene ciloleucel in patients with large B-cell lymphomaLorena Panaite, Qian Vicky Wu, Jenna Voutsinas, et al.
Hong Kong Medical Journal = Xianggang Yi Xue Za Zhi|February 8, 2012
Effect of influenza on cardiorespiratory and all-cause mortality in Hong Kong, Singapore and GuangzhouC M Wong, J S M Peiris, L Yang, et al.
Plos One|April 6, 2017
Development of an enzyme immunoassay for detection of antibodies against Coccidioides in dogs and other mammalian speciesNancy A Chow, Mark D Lindsley, Orion Z McCotter, et al.
Pageof 44